PER-068-10已完成未知
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 100（—）
- 性别
- All
入选标准
- •Age greater than or equal to 18 years
- •Ability to provide informed consent or assent.
- •Previous participation in a hyponatremia trial with lixivaptan with evidence of desire or need to continue therapy. Patients must have demonstrated acceptable compliance with the experimental medication (> 70% of the prescribed medication taken) and adherence to the study procedures in the original trial.
排除标准
- •A current medical condition for which long-term treatment with an aquatic agent may pose an undue risk to the patient.
- •Hyponatremia which is acute, reversible, artificial or caused by conditions not associated with excess vasopressin or that may respond to aquatic therapy.
- •Hyponatremia caused by a reversible medical therapy or condition
- •Conditions associated with an imminent independent risk of morbidity and mortality.
研究者
相似试验
已完成
3 期
International, Multicenter, Study of a Twenty-Eight Week,Open-Label, Titrated Oral Lixivaptan Administration inPatients with Chronic Hyponatremia: Extension to StudiesCK-LX3401, 3405, and 3430CTRI/2010/091/000335CARDIOKINE150
进行中（未招募）
不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - OleChronic hyponatraemiaMedDRA version: 12.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2009-016371-30-DECardiokine Biopharma LLC150
进行中（未招募）
不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - OleChronic hyponatraemiaMedDRA version: 12.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2009-016371-30-BECardiokine Biopharma LLC150
进行中（未招募）
不适用
International, multi-center, study of a twenty-eight week, open-label, titrated oral lixivaptan administration in patients with chronic hyponatremia: extension to studies CK-LX3401, 3405, and 3430 - OleChronic hyponatraemiaMedDRA version: 12.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2009-016371-30-CZCardiokine Biopharma LLC150
进行中（未招募）
1 期
A clinical study with many of countries and sites participating. This study wants to look into the relationship of the genotype IL28B in patients from all over the world which are suffering from an inflammation of the liver with hepatitis C virusEUCTR2011-001096-39-SKF.Hoffmann-La Roche Ltd.4,200